Press Release

The "Bone repair & regeneration Pipeline Highlights - 2017 Update" drug pipelines has been added to ResearchAndMarkets.com's offering.

This report covers emerging therapies for Bone repair & regeneration in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development strategies, and executing in-licensing and out-licensing deals.

Clinical Trial Stages:

The report provides Bone repair & regeneration pipeline products by clinical trial stages including both early and late stage development - phase 3 clinical trials, phase 2 clinical trials, phase 1 clinical trials, preclinical research, and discovery stage.

Drug Mechanism Classes:

The report provides Bone repair & regeneration pipeline products by their dominant mechanism of action. This helps executives categorize products based on their drug class and also assess the strengths and weaknesses of compounds.

Company:

The report provides Bone repair & regeneration pipeline products by the company.

Short-term Launch Highlights:

Find out which Bone repair & regeneration pipeline products will be launched in the US and Ex-US till 2020.

Summary:

• Bone repair & regeneration phase 3 clinical trial pipeline products
• Bone repair & regeneration phase 2 clinical trial pipeline products
• Bone repair & regeneration phase 1 clinical trial pipeline products
• Bone repair & regeneration preclinical research pipeline products
• Bone repair & regeneration discovery stage pipeline products
• Bone repair & regeneration pipeline products short-term launch highlights

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/cbkpcc/2017_bone_repair?w=4

View source version on businesswire.com: http://www.businesswire.com/news/home/20180309005336/en/

Last updated on: 09/03/2018